| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |